Summit Financial »

Vaneck Vectors Pharmaceutical etf shares owned by Summit Financial

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Summit Financial from 13F filings

Historical chart of Summit Financial investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Summit Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Summit Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $348k 3.8k 90.70

More positions owned by Summit Financial

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Ishares Tr Msci Eafe Etf (EFA)
Summit Financial
Ishares Tr Core Us Aggbd Et (AGG)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Mcp Etf (IJH)
Exxon Mobil Corporation (XOM)
Ishares Tr Select Divid Etf (DVY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
CSX Corporation (CSX)

View all positions for Summit Financial

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Thrivent Financial for Lutherans
Miller Investment Management
Mivtachim The Workers Social Insurance Fund
Northwestern Mutual Wealth Management Company
Adamsbrown Wealth Consultants
Prime Capital Investment Advisors
Bank of America Corporation
LPL Financial
Phoenix Holdings
J.Safra Asset Management
Citadel Advisors
WT Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf